Compare AYTU & ORIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AYTU | ORIO |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | Canada |
| Employees | N/A | 188 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.4M | 23.0M |
| IPO Year | 2015 | N/A |
| Metric | AYTU | ORIO |
|---|---|---|
| Price | $2.16 | $0.88 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $9.33 | N/A |
| AVG Volume (30 Days) | 23.4K | ★ 32.4K |
| Earning Date | 05-13-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $27,632,080.00 | N/A |
| Revenue This Year | N/A | $74.52 |
| Revenue Next Year | $43.75 | $5.07 |
| P/E Ratio | ★ N/A | $4.93 |
| Revenue Growth | ★ 277.47 | N/A |
| 52 Week Low | $1.65 | $0.81 |
| 52 Week High | $3.07 | $1.40 |
| Indicator | AYTU | ORIO |
|---|---|---|
| Relative Strength Index (RSI) | 45.37 | 37.56 |
| Support Level | $2.08 | N/A |
| Resistance Level | $2.32 | $0.98 |
| Average True Range (ATR) | 0.09 | 0.06 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 33.39 | 7.13 |
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.
Orion Digital Corp is a financial technology company operating digital platforms across wealth and payments, supported by a consumer lending business in Canada. The Company's Wealth platform, Intelligent Investing, provides long-term investment solutions to the Canadian market. It also operates a consumer lending business in Canada. Its Payments business is conducted through its wholly owned subsidiary, which provides issuer processing, program management, and regulated payment orchestration services across Europe. The Company operates in Canada and Europe, with Canada generating the majority of its revenue.